My NCBISign In
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
Graham A Colditz
Breast Cancer Res. 2007; 9(4): 108. Published online 2007 July 26. doi: 10.1186/bcr1736
Correction in:
Breast Cancer Res. 2007; 9(6): 401.
PMCID:
PMC2206710
Abstract Full Text PDF–39K Correction

Is Cited by the Following 5 Articles in this Archive:

Applying What We Know to Accelerate Cancer Prevention
Graham A. Colditz, Kathleen Y. Wolin, Sarah Gehlert
Sci Transl Med. Author manuscript; available in PMC 2012 September 28.
Published in final edited form as: Sci Transl Med. 2012 March 28; 4(127): 127rv4. doi: 10.1126/scitranslmed.3003218
PMCID:
PMC3343638
Free in PMC on 2012/09/28
The Contribution of Postmenopausal Hormone Use Cessation to the Declining Incidence of Breast Cancer
Brian L. Sprague, Amy Trentham-Dietz, Patrick L. Remington
Cancer Causes Control. Author manuscript; available in PMC 2012 January 1.
Published in final edited form as: Cancer Causes Control. 2011 January; 22(1): 125–134. Published online 2010 November 16. doi: 10.1007/s10552-010-9682-7
PMCID:
PMC3034386
Abstract Full Text PDF–669K
Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats
Athena Starlard-Davenport, Volodymyr P. Tryndyak, Smitha R. James, Adam R. Karpf, John R. Latendresse, Frederick A. Beland, Igor P. Pogribny
Carcinogenesis. 2010 March; 31(3): 376–381. Published online 2009 December 14. doi: 10.1093/carcin/bgp304
PMCID:
PMC2899845
Abstract Full Text PDF–1019K Supplementary Material
Rates of atypical ductal hyperplasia have declined with less use of post-menopausal hormone treatment. Findings from the Breast Cancer Surveillance Consortium
Tehillah S. Menes, Karla Kerlikowske, Shabnam Jaffer, Deborah Seger, Diana L. Miglioretti
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2010 November 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 November; 18(11): 2822–2828. doi: 10.1158/1055-9965.EPI-09-0745
PMCID:
PMC2920735
Abstract Full Text PDF–681K
Correction: Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
Graham A Colditz
Breast Cancer Res. 2007; 9(6): 401. Published online 2007 November 15. doi: 10.1186/bcr1786
Corrects:
Breast Cancer Res. 2007; 9(4): 108.
PMCID:
PMC2246169
Correction PDF–29K Original Article
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk